Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TAK-500
i
Other names:
TAK-500, TAK 500, TAK500
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Takeda
Drug class:
STING agonist, CCR2-targeted antibody-drug conjugate
Related drugs:
‹
CS-1018 (2)
XMT-2056 (2)
CS-1010 (1)
CS-1020 (1)
ACTM-838 (0)
ADU-S100 (0)
BI 1387446 (0)
E7766 (0)
GSK3745417 (0)
IMSA101 (0)
MK-2118 (0)
ONM-501 (0)
SB 11285 (0)
SYNB1891 (0)
TSN222 (0)
TAK-676 (0)
exoSTING (0)
MK-1454 (0)
CS-1018 (2)
XMT-2056 (2)
CS-1010 (1)
CS-1020 (1)
ACTM-838 (0)
ADU-S100 (0)
BI 1387446 (0)
E7766 (0)
GSK3745417 (0)
IMSA101 (0)
MK-2118 (0)
ONM-501 (0)
SB 11285 (0)
SYNB1891 (0)
TSN222 (0)
TAK-676 (0)
exoSTING (0)
MK-1454 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CCR2 overexpression
Non Small Cell Lung Cancer
CCR2 overexpression
Non Small Cell Lung Cancer
TAK-500
Sensitive: D – Preclinical
TAK-500
Sensitive
:
D
TAK-500
Sensitive: D – Preclinical
TAK-500
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login